United States · FDA National Drug Code directory
TOFACITINIB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71085-099_56a8aa5c-a9a1-b977-e063-6294a90aa496
- Product NDC
- 71085-099
- Form
- SOLUTION
- Composition / generic term
- Tofacitinib
- Labeler
- IPG Pharmaceuticals, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260615
- Source listing expiry
- 20271231
Source-listed ingredients
- TOFACITINIB CITRATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (71085-099-24) / 240 mL in 1 BOTTLE · 71085-099-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →